Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp

Bullboard Posts

Post by septbugleon Dec 01, 2016 10:23am

164 Views

Post# 25539763

HEY US. TECHINVESTER

Was just couriuos if you were able to get rid of your shares on that last news release or are you waiting for the really bad release next.The new ceo said tests were good so far this will be the turning point one way or the other.Iam not selling until iknow one way or another. With good results and if the new ceo meets his first deadline should be tremendous upside from this point untill that happens we will still drift down.If they fail we all fail. GLTA

Bullboard Posts

The long-term forecast for lithium stocks in 2024